Alison L. Hannah
EVP, Chief Medical Officer · RIGEL PHARMACEUTICALS INC
Individual
- 2025
- Jul 11, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Alison L. Hannah files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Greg D. Aunan - $321K in NEO purchases and sales in the last 12 months
- Alicia C. Olivo - $300K in NEO purchases and sales in the last 12 months
- Warren Stone - $277K in NEO purchases and sales in the last 12 months
- Kamil Ali-Jackson - $160K in RIGL purchases and sales in the last 12 months
- Walter H. Moos - $145K in RIGL purchases and sales in the last 12 months
- Lynn A. Tetrault - $119K in NEO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Alison L. Hannah?
Alison L. Hannah is a corporate insider, tracked as EVP, Chief Medical Officer of RIGEL PHARMACEUTICALS INC (RIGL). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Alison L. Hannah last file a Form 4?
The most recent primary Form 4 on record is dated 11 July 2026, one of 4 filings going back to 2025.
